ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί
Jeon‐Soo Lee(National Cancer Center), Sung‐Ho Goh(National Cancer Center)
Cited by 9
Related Papers
CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer
|Scientific Reports|2017|25
Synergistic Enhancement of Antitumor Effects by Combining Abemaciclib with Desipramine
|International Journal of Molecular Sciences|2024|2